Skip to main content
logo
Biogen Inc. (BIIB)
NASDAQ: BIIB · Real-Time Price · USD
249.01
-4.61 (-1.82%)
At close: Nov 2, 2026, 4:00 PM EST
247.23
-1.78 (-0.71%)
After-hours: Nov 2, 2026, 4:25 PM EST

Biogen Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
10,2979,8919,6769,83610,17310,982
Revenue Growth
2.30%2.22%-1.62%-3.32%-7.36%-18.32%
Gross Profit
7,8027,8087,5477,3027,8958,872
Operating Income
2,4202,8482,6141,8993,0193,436
Net Income
347.51,2931,6321,1613,0471,556
Earnings Per Share
2.348.7911.187.9720.8710.40
EPS Growth
-78.71%-21.38%40.28%-61.81%100.67%-58.06%

Revenue by Segment
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Multiple Sclerosis Product
3,7574,0394,3504,6625,4306,097
Rare Disease Product
2,3502,1541,9881,8031,7941,905
Biosimilars Product
670.7729.1793.1770751.1831.1
Other Product
276.3197.282.511.81314
Other
3,2432,7712,4622,5892,1862,135
Revenue (Total)
10,2979,8919,6769,83610,17310,982

Cash & Debt
Chart
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
1,3044,2482,3751,0505,5994,695
Total Debt
7,8016,6586,7177,4296,7117,693
Net Cash (Debt)
-6,497-2,410-4,342-6,379-1,113-2,998
Net Cash Growth
------
Net Cash Per Share
-43.70-16.38-29.76-43.81-7.62-20.04

Cash Flow & CapEx
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
2,2472,2052,8761,5471,3843,640
Capital Expenditures
-176.4-153.8-153.7-277-240.3-258.1
Free Cash Flow
2,0712,0512,7221,2701,1443,382
Free Cash Flow Growth
-10.14%-24.65%114.28%11.03%-66.17%-11.12%

Margins
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
75.77%78.95%78.00%74.24%77.61%80.79%
Operating Margin
23.50%28.79%27.02%19.30%29.67%31.29%
Pretax Margin
4.32%15.74%19.70%13.18%35.33%16.21%
Profit Margin
3.38%13.07%16.87%11.80%29.95%14.17%
FCF Margin
20.11%20.73%28.13%12.91%11.24%30.80%

Valuation
Chart
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
106.5919.9713.6532.2913.0922.65
Forward PE
16.8813.669.7117.5417.7013.94
P/FCF Ratio
17.8312.598.1929.5234.8610.42
PS Ratio
3.592.612.303.813.923.21